Kewaunee Scientific (NASDAQ: KEQU) CEO receives 15,195 RSUs in equity grant

Rhea-AI Filing Summary

HULL THOMAS DAVID III reported acquisition or exercise transactions in this Form 4 filing.

KEWAUNEE SCIENTIFIC CORP President & CEO Thomas David Hull III reported an equity compensation grant in the form of restricted stock units. He received 15,195 RSUs tied to the company’s common stock, each representing a contingent right to one share, with no cash paid per unit.

The RSUs will vest in three equal annual installments starting on June 30, 2027, as long as he remains employed by the company. Following this award, his reported holdings for this RSU grant total 15,195 units directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider HULL THOMAS DAVID III

Role President & CEO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units FY27	15,195	$0.00	--

Holdings After Transaction: Restricted Stock Units FY27 — 15,195 shares (Direct, null)

Footnotes (1)

1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units shall vest in three equal annual installments beginning June 30, 2027, subject to the reporting person's continued employment with the Company.

Key Figures

RSUs granted: 15,195 units Grant price per RSU: $0.0000 per unit Underlying common shares: 15,195 shares +3 more

6 metrics

RSUs granted 15,195 units Restricted Stock Units FY27 grant to President & CEO

Grant price per RSU $0.0000 per unit Compensation grant, no cash paid by insider

Underlying common shares 15,195 shares Each RSU represents one share of common stock

Holdings after transaction 15,195 RSUs Total for this FY27 award following the grant

Vesting start date June 30, 2027 First of three equal annual vesting installments

Number of vesting installments 3 annual installments RSUs vest over three years starting June 30, 2027

Key Terms

Restricted Stock Units, contingent right, vest, Common Stock

4 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."

vest financial

"The restricted stock units shall vest in three equal annual installments beginning June 30, 2027, subject to the reporting person's continued employment with the Company."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Common Stock financial

"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/25/2026 - 04:28 PM Accepted by SEC EDGAR 06/25/2026 - 04:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HULL THOMAS DAVID III

(Last) (First) (Middle)

2700 WEST FRONT STREET

(Street)

STATESVILLE NORTH CAROLINA 28677

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units FY27	(1)	06/24/2026		A		15,195		(2)	(2)	Common Stock	15,195	$0	15,195	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

2. The restricted stock units shall vest in three equal annual installments beginning June 30, 2027, subject to the reporting person's continued employment with the Company.

Remarks:

	/s/ Donald T. Gardner III, Attorney-in-fact	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did KEQU President & CEO Thomas David Hull III report?

Thomas David Hull III reported receiving a grant of 15,195 restricted stock units as equity compensation. Each unit is tied to one share of KEWAUNEE SCIENTIFIC CORP common stock, providing future share delivery subject to vesting conditions and continued employment.

How many KEQU restricted stock units were granted to the CEO in this Form 4?

The CEO was granted 15,195 restricted stock units labeled for FY27. These RSUs are derivative securities that convert into an equal number of common shares over time, assuming vesting conditions are satisfied and employment with KEWAUNEE SCIENTIFIC CORP is maintained.

What are the vesting terms for the KEQU FY27 restricted stock units?

The FY27 restricted stock units vest in three equal annual installments beginning June 30, 2027. Vesting is contingent on the reporting person’s continued employment with KEWAUNEE SCIENTIFIC CORP, aligning long-term incentives with the company’s performance and retention objectives.

Did the KEQU CEO buy or sell shares in the market in this filing?

No open-market buying or selling occurred; this Form 4 reflects a grant of restricted stock units. The transaction is compensation-related, with 15,195 RSUs awarded at a stated price of zero, rather than a discretionary purchase or sale of common stock.

How many KEQU RSUs does the CEO hold after this reported grant?

After this transaction, the Form 4 shows the CEO holding 15,195 restricted stock units associated with this specific FY27 award. These units represent contingent rights to receive the company’s common shares as they vest over the defined three-year schedule.